Review





Similar Products

tris  (TaKaRa)
96
TaKaRa tris
Tris, supplied by TaKaRa, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/edta/Tris-Borate-EDTA+Buffer+(TBE)+Powder/pmc13635745-141-14-16
Average 96 stars, based on 1 article reviews
tris - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier

90
PanReac AppliChem ethylenediamine tetraacetic acid (edta, 99.0
Ethylenediamine Tetraacetic Acid (Edta, 99.0, supplied by PanReac AppliChem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/edta/ethylenediaminetetraacetic+acid++edta+/10__34294_slash_j__jsta__26__21__120-80-0-8
Average 90 stars, based on 1 article reviews
ethylenediamine tetraacetic acid (edta, 99.0 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

86
Sarstedt edta tubes
Edta Tubes, supplied by Sarstedt, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/edta/edta+tubes/pmc13264095-565-9-11
Average 86 stars, based on 1 article reviews
edta tubes - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

94
Valiant Co Ltd ethylenediaminetetraacetic acid edta
Epithelial barrier integrity assessment in 3D enteroids in suspension (A) Expression of important tight junction proteins in MBO, AO, and BO as compared to primary enterocyte and jejunal mucosa in vivo levels. Data are shown as mean ± SD. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001 (DEqMS); ND = not detected; NQ = not quantified. Data from different donors is shown ( n = 4 enteroid donors Hu18-9jej, Hu22-2jej, Hu22-3jej, Hu22-5jej; n = 4 enterocyte donors Hu21-7jej, Hu21-14jej, Hu22-3jej, Hu22-5jej and n = 5 jejunal mucosa donors Hu21-7jej, Hu21-14jej, Hu22-2jej, Hu22-3jej, Hu22-5jej). (B and D) Representative time-lapse series showing suspended (B) AO and (D) BO enteroids that were incubated in medium containing lucifer yellow (LY, 100 μM) at 37°C to assess intact epithelial barrier over a time period of 90 min. AO enteroids were imaged live by confocal microscopy, and LY fluorescence intensity was determined within the outline of the enteroid and background. Scale bars, 50 μm. Images are representative of 44 AO and BO enteroid observations. (C and E) Quantification of LY fluorescence intensity within enteroids was normalized to background. For the experiment, an average of 44 enteroid observations per time point was made; the Kruskal-Wallis test showed no statistically significant difference between time points. Data are shown as median ± IQR. Data are representative as one of two independent experiments. (F and G) Incubation with Ca 2+ chelator <t>EDTA</t> disrupts paracellular barrier integrity in (F) AO and (G) BO enteroids. The LY permeability assay was used to evaluate apical-out enteroids treated with EDTA for 30 min. Enteroids were imaged as described in (B and D) using live-cell confocal microscopy. Scale bars, 50 μm. The corresponding quantification of LY fluorescence intensity within untreated enteroids (incubation with LY for 30 min) and enteroids treated with EDTA (additional incubation for 30 min with EDTA) was normalized to background. Data are shown as median ± IQR. An average of 44 enteroid observations were analyzed; ∗∗∗∗ p < 0.0001 (Mann-Whitney U test). (B–G) Enteroids from donor Hu18-9jej were used. See also .
Ethylenediaminetetraacetic Acid Edta, supplied by Valiant Co Ltd, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/edta/Ethylenediaminetetraacetic+acid/pmc13657221-54-0-4
Average 94 stars, based on 1 article reviews
ethylenediaminetetraacetic acid edta - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

95
Cytiva Europe sh30256 01 trypsin edta
Epithelial barrier integrity assessment in 3D enteroids in suspension (A) Expression of important tight junction proteins in MBO, AO, and BO as compared to primary enterocyte and jejunal mucosa in vivo levels. Data are shown as mean ± SD. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001 (DEqMS); ND = not detected; NQ = not quantified. Data from different donors is shown ( n = 4 enteroid donors Hu18-9jej, Hu22-2jej, Hu22-3jej, Hu22-5jej; n = 4 enterocyte donors Hu21-7jej, Hu21-14jej, Hu22-3jej, Hu22-5jej and n = 5 jejunal mucosa donors Hu21-7jej, Hu21-14jej, Hu22-2jej, Hu22-3jej, Hu22-5jej). (B and D) Representative time-lapse series showing suspended (B) AO and (D) BO enteroids that were incubated in medium containing lucifer yellow (LY, 100 μM) at 37°C to assess intact epithelial barrier over a time period of 90 min. AO enteroids were imaged live by confocal microscopy, and LY fluorescence intensity was determined within the outline of the enteroid and background. Scale bars, 50 μm. Images are representative of 44 AO and BO enteroid observations. (C and E) Quantification of LY fluorescence intensity within enteroids was normalized to background. For the experiment, an average of 44 enteroid observations per time point was made; the Kruskal-Wallis test showed no statistically significant difference between time points. Data are shown as median ± IQR. Data are representative as one of two independent experiments. (F and G) Incubation with Ca 2+ chelator <t>EDTA</t> disrupts paracellular barrier integrity in (F) AO and (G) BO enteroids. The LY permeability assay was used to evaluate apical-out enteroids treated with EDTA for 30 min. Enteroids were imaged as described in (B and D) using live-cell confocal microscopy. Scale bars, 50 μm. The corresponding quantification of LY fluorescence intensity within untreated enteroids (incubation with LY for 30 min) and enteroids treated with EDTA (additional incubation for 30 min with EDTA) was normalized to background. Data are shown as median ± IQR. An average of 44 enteroid observations were analyzed; ∗∗∗∗ p < 0.0001 (Mann-Whitney U test). (B–G) Enteroids from donor Hu18-9jej were used. See also .
Sh30256 01 Trypsin Edta, supplied by Cytiva Europe, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/edta/HyClone+PBS+liquid/pm42835088-475-186-184
Average 95 stars, based on 1 article reviews
sh30256 01 trypsin edta - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier

96
Beijing Solarbio Science trypsin edta solution
Epithelial barrier integrity assessment in 3D enteroids in suspension (A) Expression of important tight junction proteins in MBO, AO, and BO as compared to primary enterocyte and jejunal mucosa in vivo levels. Data are shown as mean ± SD. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001 (DEqMS); ND = not detected; NQ = not quantified. Data from different donors is shown ( n = 4 enteroid donors Hu18-9jej, Hu22-2jej, Hu22-3jej, Hu22-5jej; n = 4 enterocyte donors Hu21-7jej, Hu21-14jej, Hu22-3jej, Hu22-5jej and n = 5 jejunal mucosa donors Hu21-7jej, Hu21-14jej, Hu22-2jej, Hu22-3jej, Hu22-5jej). (B and D) Representative time-lapse series showing suspended (B) AO and (D) BO enteroids that were incubated in medium containing lucifer yellow (LY, 100 μM) at 37°C to assess intact epithelial barrier over a time period of 90 min. AO enteroids were imaged live by confocal microscopy, and LY fluorescence intensity was determined within the outline of the enteroid and background. Scale bars, 50 μm. Images are representative of 44 AO and BO enteroid observations. (C and E) Quantification of LY fluorescence intensity within enteroids was normalized to background. For the experiment, an average of 44 enteroid observations per time point was made; the Kruskal-Wallis test showed no statistically significant difference between time points. Data are shown as median ± IQR. Data are representative as one of two independent experiments. (F and G) Incubation with Ca 2+ chelator <t>EDTA</t> disrupts paracellular barrier integrity in (F) AO and (G) BO enteroids. The LY permeability assay was used to evaluate apical-out enteroids treated with EDTA for 30 min. Enteroids were imaged as described in (B and D) using live-cell confocal microscopy. Scale bars, 50 μm. The corresponding quantification of LY fluorescence intensity within untreated enteroids (incubation with LY for 30 min) and enteroids treated with EDTA (additional incubation for 30 min with EDTA) was normalized to background. Data are shown as median ± IQR. An average of 44 enteroid observations were analyzed; ∗∗∗∗ p < 0.0001 (Mann-Whitney U test). (B–G) Enteroids from donor Hu18-9jej were used. See also .
Trypsin Edta Solution, supplied by Beijing Solarbio Science, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/edta/Trypsin-EDTA+2%2E5%25/pm42826847-66-0-7
Average 96 stars, based on 1 article reviews
trypsin edta solution - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier

98
TargetMol edta free phosphatase inhibitor i
Epithelial barrier integrity assessment in 3D enteroids in suspension (A) Expression of important tight junction proteins in MBO, AO, and BO as compared to primary enterocyte and jejunal mucosa in vivo levels. Data are shown as mean ± SD. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001 (DEqMS); ND = not detected; NQ = not quantified. Data from different donors is shown ( n = 4 enteroid donors Hu18-9jej, Hu22-2jej, Hu22-3jej, Hu22-5jej; n = 4 enterocyte donors Hu21-7jej, Hu21-14jej, Hu22-3jej, Hu22-5jej and n = 5 jejunal mucosa donors Hu21-7jej, Hu21-14jej, Hu22-2jej, Hu22-3jej, Hu22-5jej). (B and D) Representative time-lapse series showing suspended (B) AO and (D) BO enteroids that were incubated in medium containing lucifer yellow (LY, 100 μM) at 37°C to assess intact epithelial barrier over a time period of 90 min. AO enteroids were imaged live by confocal microscopy, and LY fluorescence intensity was determined within the outline of the enteroid and background. Scale bars, 50 μm. Images are representative of 44 AO and BO enteroid observations. (C and E) Quantification of LY fluorescence intensity within enteroids was normalized to background. For the experiment, an average of 44 enteroid observations per time point was made; the Kruskal-Wallis test showed no statistically significant difference between time points. Data are shown as median ± IQR. Data are representative as one of two independent experiments. (F and G) Incubation with Ca 2+ chelator <t>EDTA</t> disrupts paracellular barrier integrity in (F) AO and (G) BO enteroids. The LY permeability assay was used to evaluate apical-out enteroids treated with EDTA for 30 min. Enteroids were imaged as described in (B and D) using live-cell confocal microscopy. Scale bars, 50 μm. The corresponding quantification of LY fluorescence intensity within untreated enteroids (incubation with LY for 30 min) and enteroids treated with EDTA (additional incubation for 30 min with EDTA) was normalized to background. Data are shown as median ± IQR. An average of 44 enteroid observations were analyzed; ∗∗∗∗ p < 0.0001 (Mann-Whitney U test). (B–G) Enteroids from donor Hu18-9jej were used. See also .
Edta Free Phosphatase Inhibitor I, supplied by TargetMol, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/edta/Protease+Inhibitor+Cocktail/pm42826720-461-50-54
Average 98 stars, based on 1 article reviews
edta free phosphatase inhibitor i - by Bioz Stars, 2026-10
98/100 stars
  Buy from Supplier

93
Greiner Bio ethylenediaminetetraacetic acid
Epithelial barrier integrity assessment in 3D enteroids in suspension (A) Expression of important tight junction proteins in MBO, AO, and BO as compared to primary enterocyte and jejunal mucosa in vivo levels. Data are shown as mean ± SD. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001 (DEqMS); ND = not detected; NQ = not quantified. Data from different donors is shown ( n = 4 enteroid donors Hu18-9jej, Hu22-2jej, Hu22-3jej, Hu22-5jej; n = 4 enterocyte donors Hu21-7jej, Hu21-14jej, Hu22-3jej, Hu22-5jej and n = 5 jejunal mucosa donors Hu21-7jej, Hu21-14jej, Hu22-2jej, Hu22-3jej, Hu22-5jej). (B and D) Representative time-lapse series showing suspended (B) AO and (D) BO enteroids that were incubated in medium containing lucifer yellow (LY, 100 μM) at 37°C to assess intact epithelial barrier over a time period of 90 min. AO enteroids were imaged live by confocal microscopy, and LY fluorescence intensity was determined within the outline of the enteroid and background. Scale bars, 50 μm. Images are representative of 44 AO and BO enteroid observations. (C and E) Quantification of LY fluorescence intensity within enteroids was normalized to background. For the experiment, an average of 44 enteroid observations per time point was made; the Kruskal-Wallis test showed no statistically significant difference between time points. Data are shown as median ± IQR. Data are representative as one of two independent experiments. (F and G) Incubation with Ca 2+ chelator <t>EDTA</t> disrupts paracellular barrier integrity in (F) AO and (G) BO enteroids. The LY permeability assay was used to evaluate apical-out enteroids treated with EDTA for 30 min. Enteroids were imaged as described in (B and D) using live-cell confocal microscopy. Scale bars, 50 μm. The corresponding quantification of LY fluorescence intensity within untreated enteroids (incubation with LY for 30 min) and enteroids treated with EDTA (additional incubation for 30 min with EDTA) was normalized to background. Data are shown as median ± IQR. An average of 44 enteroid observations were analyzed; ∗∗∗∗ p < 0.0001 (Mann-Whitney U test). (B–G) Enteroids from donor Hu18-9jej were used. See also .
Ethylenediaminetetraacetic Acid, supplied by Greiner Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/edta/Vacuette+Tube+4+Ml+K2E+K2Edta/10__3390_slash_pathogens15101042-58-4-12
Average 93 stars, based on 1 article reviews
ethylenediaminetetraacetic acid - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

99
MedChemExpress edta free protease inhibitor cocktail
Epithelial barrier integrity assessment in 3D enteroids in suspension (A) Expression of important tight junction proteins in MBO, AO, and BO as compared to primary enterocyte and jejunal mucosa in vivo levels. Data are shown as mean ± SD. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001 (DEqMS); ND = not detected; NQ = not quantified. Data from different donors is shown ( n = 4 enteroid donors Hu18-9jej, Hu22-2jej, Hu22-3jej, Hu22-5jej; n = 4 enterocyte donors Hu21-7jej, Hu21-14jej, Hu22-3jej, Hu22-5jej and n = 5 jejunal mucosa donors Hu21-7jej, Hu21-14jej, Hu22-2jej, Hu22-3jej, Hu22-5jej). (B and D) Representative time-lapse series showing suspended (B) AO and (D) BO enteroids that were incubated in medium containing lucifer yellow (LY, 100 μM) at 37°C to assess intact epithelial barrier over a time period of 90 min. AO enteroids were imaged live by confocal microscopy, and LY fluorescence intensity was determined within the outline of the enteroid and background. Scale bars, 50 μm. Images are representative of 44 AO and BO enteroid observations. (C and E) Quantification of LY fluorescence intensity within enteroids was normalized to background. For the experiment, an average of 44 enteroid observations per time point was made; the Kruskal-Wallis test showed no statistically significant difference between time points. Data are shown as median ± IQR. Data are representative as one of two independent experiments. (F and G) Incubation with Ca 2+ chelator <t>EDTA</t> disrupts paracellular barrier integrity in (F) AO and (G) BO enteroids. The LY permeability assay was used to evaluate apical-out enteroids treated with EDTA for 30 min. Enteroids were imaged as described in (B and D) using live-cell confocal microscopy. Scale bars, 50 μm. The corresponding quantification of LY fluorescence intensity within untreated enteroids (incubation with LY for 30 min) and enteroids treated with EDTA (additional incubation for 30 min with EDTA) was normalized to background. Data are shown as median ± IQR. An average of 44 enteroid observations were analyzed; ∗∗∗∗ p < 0.0001 (Mann-Whitney U test). (B–G) Enteroids from donor Hu18-9jej were used. See also .
Edta Free Protease Inhibitor Cocktail, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/edta/Protease+Inhibitor+Cocktail/10__1007_slash_s13402___026___01300___8-75-21-25
Average 99 stars, based on 1 article reviews
edta free protease inhibitor cocktail - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier

94
Greiner Bio edta tubes
Epithelial barrier integrity assessment in 3D enteroids in suspension (A) Expression of important tight junction proteins in MBO, AO, and BO as compared to primary enterocyte and jejunal mucosa in vivo levels. Data are shown as mean ± SD. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001 (DEqMS); ND = not detected; NQ = not quantified. Data from different donors is shown ( n = 4 enteroid donors Hu18-9jej, Hu22-2jej, Hu22-3jej, Hu22-5jej; n = 4 enterocyte donors Hu21-7jej, Hu21-14jej, Hu22-3jej, Hu22-5jej and n = 5 jejunal mucosa donors Hu21-7jej, Hu21-14jej, Hu22-2jej, Hu22-3jej, Hu22-5jej). (B and D) Representative time-lapse series showing suspended (B) AO and (D) BO enteroids that were incubated in medium containing lucifer yellow (LY, 100 μM) at 37°C to assess intact epithelial barrier over a time period of 90 min. AO enteroids were imaged live by confocal microscopy, and LY fluorescence intensity was determined within the outline of the enteroid and background. Scale bars, 50 μm. Images are representative of 44 AO and BO enteroid observations. (C and E) Quantification of LY fluorescence intensity within enteroids was normalized to background. For the experiment, an average of 44 enteroid observations per time point was made; the Kruskal-Wallis test showed no statistically significant difference between time points. Data are shown as median ± IQR. Data are representative as one of two independent experiments. (F and G) Incubation with Ca 2+ chelator <t>EDTA</t> disrupts paracellular barrier integrity in (F) AO and (G) BO enteroids. The LY permeability assay was used to evaluate apical-out enteroids treated with EDTA for 30 min. Enteroids were imaged as described in (B and D) using live-cell confocal microscopy. Scale bars, 50 μm. The corresponding quantification of LY fluorescence intensity within untreated enteroids (incubation with LY for 30 min) and enteroids treated with EDTA (additional incubation for 30 min with EDTA) was normalized to background. Data are shown as median ± IQR. An average of 44 enteroid observations were analyzed; ∗∗∗∗ p < 0.0001 (Mann-Whitney U test). (B–G) Enteroids from donor Hu18-9jej were used. See also .
Edta Tubes, supplied by Greiner Bio, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/edta/Vacuette+Tube+4+Ml+K3E+K3Edta/10__1038_slash_s41598___026___72488___w-44-5-7
Average 94 stars, based on 1 article reviews
edta tubes - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

Image Search Results


Epithelial barrier integrity assessment in 3D enteroids in suspension (A) Expression of important tight junction proteins in MBO, AO, and BO as compared to primary enterocyte and jejunal mucosa in vivo levels. Data are shown as mean ± SD. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001 (DEqMS); ND = not detected; NQ = not quantified. Data from different donors is shown ( n = 4 enteroid donors Hu18-9jej, Hu22-2jej, Hu22-3jej, Hu22-5jej; n = 4 enterocyte donors Hu21-7jej, Hu21-14jej, Hu22-3jej, Hu22-5jej and n = 5 jejunal mucosa donors Hu21-7jej, Hu21-14jej, Hu22-2jej, Hu22-3jej, Hu22-5jej). (B and D) Representative time-lapse series showing suspended (B) AO and (D) BO enteroids that were incubated in medium containing lucifer yellow (LY, 100 μM) at 37°C to assess intact epithelial barrier over a time period of 90 min. AO enteroids were imaged live by confocal microscopy, and LY fluorescence intensity was determined within the outline of the enteroid and background. Scale bars, 50 μm. Images are representative of 44 AO and BO enteroid observations. (C and E) Quantification of LY fluorescence intensity within enteroids was normalized to background. For the experiment, an average of 44 enteroid observations per time point was made; the Kruskal-Wallis test showed no statistically significant difference between time points. Data are shown as median ± IQR. Data are representative as one of two independent experiments. (F and G) Incubation with Ca 2+ chelator EDTA disrupts paracellular barrier integrity in (F) AO and (G) BO enteroids. The LY permeability assay was used to evaluate apical-out enteroids treated with EDTA for 30 min. Enteroids were imaged as described in (B and D) using live-cell confocal microscopy. Scale bars, 50 μm. The corresponding quantification of LY fluorescence intensity within untreated enteroids (incubation with LY for 30 min) and enteroids treated with EDTA (additional incubation for 30 min with EDTA) was normalized to background. Data are shown as median ± IQR. An average of 44 enteroid observations were analyzed; ∗∗∗∗ p < 0.0001 (Mann-Whitney U test). (B–G) Enteroids from donor Hu18-9jej were used. See also .

Journal: iScience

Article Title: Proteomic and functional profiling of suspended jejunal enteroids reveals pharmacokinetic fidelity to native intestine

doi: 10.1016/j.isci.2026.117654

Figure Lengend Snippet: Epithelial barrier integrity assessment in 3D enteroids in suspension (A) Expression of important tight junction proteins in MBO, AO, and BO as compared to primary enterocyte and jejunal mucosa in vivo levels. Data are shown as mean ± SD. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001 (DEqMS); ND = not detected; NQ = not quantified. Data from different donors is shown ( n = 4 enteroid donors Hu18-9jej, Hu22-2jej, Hu22-3jej, Hu22-5jej; n = 4 enterocyte donors Hu21-7jej, Hu21-14jej, Hu22-3jej, Hu22-5jej and n = 5 jejunal mucosa donors Hu21-7jej, Hu21-14jej, Hu22-2jej, Hu22-3jej, Hu22-5jej). (B and D) Representative time-lapse series showing suspended (B) AO and (D) BO enteroids that were incubated in medium containing lucifer yellow (LY, 100 μM) at 37°C to assess intact epithelial barrier over a time period of 90 min. AO enteroids were imaged live by confocal microscopy, and LY fluorescence intensity was determined within the outline of the enteroid and background. Scale bars, 50 μm. Images are representative of 44 AO and BO enteroid observations. (C and E) Quantification of LY fluorescence intensity within enteroids was normalized to background. For the experiment, an average of 44 enteroid observations per time point was made; the Kruskal-Wallis test showed no statistically significant difference between time points. Data are shown as median ± IQR. Data are representative as one of two independent experiments. (F and G) Incubation with Ca 2+ chelator EDTA disrupts paracellular barrier integrity in (F) AO and (G) BO enteroids. The LY permeability assay was used to evaluate apical-out enteroids treated with EDTA for 30 min. Enteroids were imaged as described in (B and D) using live-cell confocal microscopy. Scale bars, 50 μm. The corresponding quantification of LY fluorescence intensity within untreated enteroids (incubation with LY for 30 min) and enteroids treated with EDTA (additional incubation for 30 min with EDTA) was normalized to background. Data are shown as median ± IQR. An average of 44 enteroid observations were analyzed; ∗∗∗∗ p < 0.0001 (Mann-Whitney U test). (B–G) Enteroids from donor Hu18-9jej were used. See also .

Article Snippet: Ethylenediaminetetraacetic acid (EDTA) , MP Biomedicals , Cat #: 2820549.

Techniques: Suspension, Expressing, In Vivo, Incubation, Confocal, Microscopy, Fluorescence, Permeability, MANN-WHITNEY